A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
IDEAYA Biosciences
IDEAYA Biosciences
Fondazione del Piemonte per l'Oncologia
Orano Med LLC
UNC Lineberger Comprehensive Cancer Center
AstraZeneca
Cedars-Sinai Medical Center
A2 Biotherapeutics Inc.
Memorial Sloan Kettering Cancer Center
Daiichi Sankyo
Indiana University
General Oncology, Inc.
DualityBio Inc.
Northern Jiangsu People's Hospital
Northern Jiangsu People's Hospital
Ruijin Hospital
University Health Network, Toronto
University Health Network, Toronto
Valent Technologies, LLC
Korea University Anam Hospital
Guangzhou University of Traditional Chinese Medicine
Tongji Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Lyell Immunopharma, Inc.
University College, London
Puerta de Hierro University Hospital
Peter MacCallum Cancer Centre, Australia
Fudan University
Esperas Pharma Inc.
Tongji Hospital
A2 Biotherapeutics Inc.
Zhejiang University
UMC Utrecht
Fudan University
HiberCell, Inc.
Biomea Fusion Inc.
UNICANCER
Stanford University
Asociación Española de Gastroenterología
Children's National Research Institute
Blueprint Medicines Corporation
Sun Yat-sen University
UNICANCER
Mundipharma Research Limited
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
University Hospital, Antwerp
Tongji Hospital
National Cancer Institute (NCI)
Aurigene Discovery Technologies Limited
Guangxi Medical University